Navega Therapeutics Announces CIRM Grant for Treatment of Chronic Pain
February 5, 2025
Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, announced the receipt of a $4M Translational Science grant from CIRM for the relief of neuropathic pain. Founder